RE-DUAL PCI outcomes have been published by the New England Journal of Medicine along with their presentation at ESC 2017. The traditional triple anti-thrombotic scheme with dual antiplatelet therapy and warfarin for patients with atrial fibrillation undergoing coronary angioplasty seems to have been left behind. This new study showed that the combination of dabigatran with a P2Y12...
Gentileza del Dr. Carlos Fava. The common femoral artery has always been treated with surgery. Thanks to the development of new generation stents and the advancement of percutaneous intervention, common femoral lesions are currently being treated with PCI. However, data on the safety of PCI vs. surgery, remain unavailable. The TECCO is multicenter study, randomized...
Read articles on the main presentations of the third day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Daniel Weilenmann, entitled “Is the PCI risk higher in patients with severe Aortic Stenosis? How can we reduce the risk?“. We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.
Read articles on the main presentations of the third day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Conrad Simpfendorfer, entitled “When is the optimal timing for PCI: before or during TAVI”. We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.
Read articles on the main presentations of the third day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Upendra Kaul, entitled “PCI vs CABG in Diabetics – Has the Scale Changed?”. We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.
Read articles on the main presentations of the first day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Gregg Stone, entitled “Left main PCI in 2017: Ready to EXCEL?”. We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.
Leia os artigos mais destacados do primeiro dia do Congresso SOLACI-CACI 2017. Neste caso, consulte a apresentação do Dr. Conrad Simpfendorfer, intitulada “How to recommend CABG or PCI on Left Main Trunk + multi-vessel disease: CCF experience and daily practice”. We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will...
The relationship between procedure volume and prognosis after a percutaneous coronary intervention remains unclear. Intuitively, we tend to think the larger the volume, the better the results and, consequently, the lower the mortality. But when analyzing the literature, we find studies for and against this thesis. Evidence does support the idea that volume improves outcomes...
Courtesy of Dr. Gustavo Leiva. Coronary Artery Bypass Graft (CABG) has traditionally been the procedure of choice in patients with left main coronary artery disease. However, the use of percutaneous techniques in this kind of lesions has been on the rise, partly due to recent research showing similar outcomes with both procedures. Unprotected left main...
Courtesy of Dr. Brian Nazareth Donato. Multiple definitions with biomarkers and variable thresholds have been proposed to diagnose post procedural MI. The last update of the Third Universal Definition of Myocardial Infarction decided to use only troponin values with a threshold >5 over the normal value, on top of the clinical evidence by ECG, echocardiography...